American Academy of Pain Medicine (AAPM) Session: Integrating Neuromodulation Into Multimodal Pain Care Featured
The majority of pain specialists deliver multimodal pain treatment, which has been shown to be more effective than individual treatments only. Multimodal treatment can be done sequentially (one treatment at a time) or in parallel (combination therapy). However, there are no guidelines for how neuromodulation can be part of this chain (sequential or parallel approaches) and perhaps used earlier on in the treatment of chronic pain, based on the growing strength of the evidence. Candidates for neuromodulation often present with some of the most complex and challenging chronic painful conditions, and it is unrealistic to expect a neuromodulation implant to resolve the many facets of chronic pain, which include not only physical pain, but deconditioning, behavioral comorbidities, and mental health co-morbidities. This session will focus on multimodal pain care in the neuromodulation patient, including adjunctive interventional therapies, medical therapies, and rehabilitation medicine approaches to help optimize neuromodulation outcomes.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Identify non-opioid analgesic adjuvant medications to help manage residual pain following a successful device implant.
- Discuss opioid tapering strategies for implant patients who remain on opioids after a successful implant.
- Explain how and why earlier implementation of neuromodulation in the treatment algorithm can improve outcomes.
- Describe behavioral strategies and interventions to optimize psychosocial function after device implantation.
Welcome
Judith Scheman, PhD
Optimal Timing of Spinal Cord Stimulation in the Treatment Algorithm Can Improve Outcomes
Jonathan M. Hagedorn, MD
The Device Is Implanted and Now You Need to Taper: How to Do It
Antje M. Barreveld, MD
Adjunctive Medical Therapy to Help Optimize Neuromodulation Outcomes
Ajay D. Wasan, MD MSc
Optimizing Psychosocial Factors in Prospective SCS Patients/Candidates
Judith Scheman, PhD
Faculty and Presentations subject to change.